These names have solid cash flows and are buying back stock, Jefferies says

S&P 500 companies are approaching $1 trillion in announced share buybacks for 2025, with year-to-date totals up 30% to $936 billion, a key factor in the index's over 8% gain in 2025. This surge, exemplified by Apple's $100 billion plan, underscores buybacks as a flexible capital return method signaling management confidence. Jefferies highlights investment opportunities in companies with high buyback yields, strong free cash flow, and solid balance sheets, citing Tenet Healthcare, which recently increased its buyback program amid strong earnings, and Qualcomm, known for substantial repurchases.

Analysis

A surge in corporate share buybacks is providing a significant tailwind for the S&P 500 in 2025, with announced repurchases totaling $936 billion, a 30% increase from the prior year and a key contributor to the index's over 8% gain. Jefferies' research highlights a specific investment thesis focused on companies with high buyback yields (>4%) supported by strong free cash flow and positive earnings outlooks. Tenet Healthcare (THC) exemplifies this profile, having surged 42% in 2025 on the back of a second-quarter earnings beat and a substantial upward revision to its full-year adjusted EPS guidance to a range of $15.55-$16.21, far exceeding its previous forecast and analyst consensus. The company reinforced this confidence by increasing its share repurchase authorization by $1.5 billion. In contrast, Mattel (MAT) presents a more complex case; while it reaffirmed a $600 million buyback target and holds significant analyst-projected upside of over 40%, it also lowered its full-year earnings forecast, creating a mixed signal for investors despite some relief from reduced tariff cost estimates. Qualcomm (QCOM) represents a third profile, offering a strong capital return narrative with $2.8 billion in recent repurchases, but its stock has remained flat, lagging semiconductor peers and suggesting a potential value proposition for investors focused on shareholder yield rather than pure momentum.

Key Decisions for Investors

• Investors should consider companies with substantial and well-funded share repurchase programs, as this is a primary driver of market performance and a signal of management confidence.
• Tenet Healthcare's combination of strong operational momentum, a significant upward earnings revision, and an increased buyback program makes it a compelling name for growth-oriented investors.
• For Mattel, the investment case hinges on its ability to offset lowered earnings guidance with tariff savings and pricing power; investors should monitor gross margin performance closely to validate the analyst-projected 40% upside.
• Qualcomm's aggressive capital return program, contrasted with its flat year-to-date stock performance, may present a value opportunity for investors seeking shareholder yield in a semiconductor sector that has otherwise seen significant appreciation.